Mycotoxin Testing Market - Global Forecast 2025-2032

The mycotoxin testing market is evolving rapidly, driven by the critical need for accurate, reliable detection across diverse food, feed, and pharmaceutical supply chains. Senior executives navigating compliance, safety, and globalization must understand the landscape’s strategic imperatives and emerging dynamics.

Market Snapshot: Mycotoxin Testing Market Growth and Outlook

The Mycotoxin Testing Market grew from USD 2.67 billion in 2024 to USD 2.88 billion in 2025. It is expected to continue growing at a CAGR of 7.92%, reaching USD 4.93 billion by 2032. This sustained expansion reflects heightened scrutiny over food and pharmaceutical safety standards globally, robust demand for analytical accuracy, and greater adoption of advanced testing technologies among laboratories, manufacturers, and regulatory entities.

Scope & Segmentation of the Mycotoxin Testing Market

• Testing Techniques: Includes Enzyme Linked Immunosorbent Assay (direct and sandwich ELISA), High Performance Liquid Chromatography (with fluorescence or UV detection), Liquid Chromatography Mass Spectrometry (high resolution LC-MS, triple quadrupole LC-MS/MS), Polymerase Chain Reaction (quantitative PCR and reverse transcriptase PCR), Rapid Test Kits (fluorescence polarization immunoassay, lateral flow assay).
• Toxin Types: Aflatoxin, fumonisin, ochratoxin, trichothecenes, zearalenone.
• Sample Types: Animal feed (mash, pellets, premix), cereals and grains (barley, maize, oats, rice, wheat), dairy products (cheese, milk, yogurt), fruits and vegetables (apples, grapes, tomatoes), nuts and seeds (almonds, peanuts, walnuts), and spices and herbs (cinnamon, pepper, turmeric).
• End Users: Animal feed producers, feed mills, environmental testing laboratories (soil, water), food and beverage processors (bakery, beverages, dairy), pharmaceutical quality control, drug formulation, and research institutes.
• Regions: Americas (North and Latin America), Europe, Middle East & Africa, Asia-Pacific. Focus markets include the United States, Canada, Brazil, Germany, China, and India among others.
• Leading Companies: Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Eurofins Scientific SE, Mérieux NutriSciences Corporation, Romer Labs Division Holding, Waters Corporation, SGS SA, RealTime Laboratories, TUV INDIA PVT LIMITED, Neogen Corporation.

Key Takeaways for Senior Decision-Makers

• Technological innovation is centered on integrated platforms combining immunoassays, high-resolution chromatographic techniques, and molecular confirmation methods to drive efficiency and testing precision.
• Automation in sample preparation and cloud-enabled data management is accelerating result turnaround, enhancing field diagnostics, and supporting decentralized testing networks.
• Strategic partnerships are fostering research, supply chain resilience, and harmonized validation, ensuring robust compliance across markets with evolving regulatory requirements.
• Segmentation strategies reflect unique challenges—ranging from livestock safety to pharmaceutical quality—to address diverse matrices and toxin profiles effectively.
• Localized manufacturing and remote support infrastructure are strengthening competitive positioning and mitigating logistical disruptions.

Tariff Impact: Navigating U.S. Policy Shifts

Revisions to U.S. tariff schedules in 2025 have elevated duties on laboratory consumables and diagnostic instrumentation. These measures have introduced cost pressures and extended supply timelines, prompting laboratories to reassess sourcing, invest in domestic capacity, and renegotiate procurement strategies. Adaptive approaches, such as switching workflows, exploring alternative chemistries, and securing service agreements, are shaping market accessibility and resilience.

Methodology & Data Sources

This report employs a mixed method approach, integrating qualitative insights from extensive primary engagements—including stakeholder interviews and targeted surveys—with rigorous quantitative analysis. Secondary research draws from peer-reviewed literature, regulatory documents, and industry standards. All insights are validated through data triangulation and expert panel review to ensure reliability and strategic relevance.

Why This Report Matters

• Supports executive-level decision-making on technology investment, risk management, and compliance strategies in the mycotoxin testing sector.
• Equips leadership with actionable intelligence to expand market reach and execute sustainable growth initiatives under evolving market and regulatory conditions.

Conclusion

The mycotoxin testing market presents both challenges and opportunities as global safety standards and technological expectations rise. This analysis delivers the strategic clarity required for stakeholders to proactively refine their approach, safeguard operations, and achieve competitive differentiation.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.